Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-17

Clinical Trial Update: β-Glucans and the Metabolic Syndrome - a Human Intervention Study Under BEST [NA]

View source ↗

Summary

This completed human intervention trial evaluated the effects of beta-glucans on metabolic syndrome-related parameters in healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • β-Glucans (beta-glucan)

Snippet

Sponsor: University of Copenhagen | Conditions: Healthy | NA | Status: COMPLETED